Back to search results

The RightCall: Improving Sepsis Diagnosis in Children

This study, called The RightCall, is testing a new Pediatric Sepsis Diagnostic Toolkit to help doctors better identify sepsis (a life-threatening response to infection) in children who are transferred to Children's Hospital Colorado. Sepsis can be harder to diagnose early in children treated in general emergency rooms. The toolkit includes recommendations for vital signs, sharing diagnostic criteria, and involving accepting physicians. Researchers will see if this toolkit improves the accuracy of sepsis diagnosis over a 24-month period after it's put into use. This study is currently unclear in its recruitment status and plans to enroll 500 participants. You may be eligible if you are a patient transferred to Children's Hospital Colorado for emergency or inpatient care who met Phoenix sepsis criteria at certain points during your care.

Study design
This study is an interventional trial that will evaluate the toolkit before and after its implementation over a total of 48 months. It aims to enroll 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome of diagnostic accuracy will be measured at the end of a 24-month post-implementation period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07051668

The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls

Recruiting
NAAges 1+InterventionalDiagnostic
University of Colorado, Denver
~500 participants
Updated 2025-08-15 on ClinicalTrials.gov
What's tested:Pediatric Sepsis Diagnostic Toolkit

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Accuracy
Measured over measured at the end of the 24 month post-implementation period

Conditions

Sepsis
Diagnosis
Emergencies

Explore related trials

Septicemia

Where it's being run

1 sites across 1 states
Colorado1

Study leadership

  • Halden F. Scott, MD, MSCS · PRINCIPAL_INVESTIGATOR · University of Colorado School of Medicine

Who to contact

Halden F. Scott, MD, MSCS
[email protected]
215-520-7217
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients transferred to Children's Hospital Colorado (CHCO) for emergency or inpatient care, as identified in the extant CHCO transfer center database AND in the extant CHCO quality improvement sepsis database AND one of the following:
Patients who met Phoenix sepsis criteria 1) in the referring ED, 2) during transport, 3) in the first 6 hours after arrival at the pediatric hospital, or 4) patients who developed Phoenix sepsis within 24 hours of arrival at the Children's Hospital underwent independent physician review by three emergency physicians. Patients in whom all three physicians agreed sepsis was most likely present, using the structured SaferDx tool were included

Exclusion

Patients less than one month of age
Patients whose transfer call recording was not available in the database

What this trial measures

  • Accuracymeasured at the end of the 24 month post-implementation period

    Proportion of included patients in whom all 3 of the following occur while the patient is physically in the referring hospital: 1) verbal or written use of the term "sepsis", 2) Intravenous antibiotics ordered,and 3) intravenous flue bolus ordered.